GE Healthcare Awarded 2021 Best in KLAS in Cardiology IT

Centricity Cardiology Enterprise ranked first amongst competitors by the industry-trusted research and insights firm. CHICAGO, Ill., February 2, 2021 – GE Healthcare has been named Best in KLAS for Cardiology IT by KLAS, an industry-trusted research and insights firm, for its Centricity™ Cardiology Enterprise[1] solution. The  Best in KLAS 2021 Software and Services Report ranks... Read more

GE Healthcare, Wayra UK to Support Startups to Develop AI Applications for Healthcare with New Accelerator Programme

The ‘Edison™ Accelerator’ Programme will give six healthcare start-ups access to world-class technical mentorship and business development support London, UK – December 17, 2020 – GE Healthcare and Wayra UK announce today the launch of GE’s regional programme to support digital health start-ups to http://www.ge.com/news/press-releases/ge-healthcare-wayra-uk-to-support-startups-to-develop-ai-applications-for-healthcare Read more

GE Healthcare Powers First-of-Its Kind Virtual ICU, Creating Access to Critical Care Specialists throughout State of Oregon

CHICAGO, December 16, 2020 – GE Healthcare today announced a multi-year agreement with Oregon Health & Science University (OHSU), Oregon’s only academic health center, that will allow OHSU to oversee and help provide care to ICU patients across eight hospital sites via a “Virtual ICU” (VICU), using the GE Healthcare Mural Virtual Care Solution. The... Read more

GE Healthcare and St. Luke’s University Health Network Accelerate Breast Cancer Care with First One-Stop Clinic in the U.S.

St. Luke’s University Health Network in Pennsylvania to serve as national model for rapid diagnostic breast cancer centers One-stop breast clinics worldwide have revolutionized patient outcomes, with same-day results for 75 percent of patients and 80 percent patient satisfaction at the flagship clinic[1] CHICAGO, IL, December 14, 2020 – GE Healthcare (NYSE: GE) today announced... Read more

GE Healthcare Completes Portfolio of Macrocyclic MRI Contrast Agent Clariscan™ (gadoterate meglumine) with U.S. FDA Approval of Clariscan in 5mL Glass Vials

The U.S. FDA has approved 5mL glass vial packaging for Clariscan (gadoterate meglumine), completing its packaging portfolio. Clariscan is now approved for patients aged two years and under, making the 5mL vials an efficient option for helping to minimize potential contrast wastage with pediatric patients. Clariscan has been approved in more than 70 countries globally,... Read more

A Better Patient Experience at SimonMed Imaging Coming with new GE MRI Tech

SCOTTSDALE, AZ – December 8, 2020 — SimonMed Imaging, one of the largest outpatient imaging providers in the US, is pleased to be the first in Arizona to bring a new, patient-friendly MRI technology to patients. SimonMed will deploy GE Healthcare’s SIGNA Architect 3T MRI scanner with new AIR http://www.ge.com/news/press-releases/a-better-patient-experience-at-simonmed-imaging-coming-with-new-ge-mri-tech Read more

GE Healthcare Expands AI, Digital and Imaging Solutions at #RSNA2020, Helping Shape Future of Healthcare in the COVID Era

CHICAGO – 29 NOVEMBER 2020 – GE Healthcare today unveiled a slate of new intelligently efficient solutions to help clinicians solve today’s two-part challenge of delivering high quality care while managing greater capacity and workflow issues, exacerbated by the impact of COVID-19. Building on http://www.ge.com/news/press-releases/ge-healthcare-expands-ai-digital-and-imaging-solutions-at-rsna2020-helping-shape Read more

GE Healthcare Expands AI, Digital and Imaging Solutions at #RSNA20, Helping Shape Future of Healthcare in the COVID Era

CHICAGO – 29 NOVEMBER 2020 –GE Healthcare today unveiled a slate of new intelligently efficient solutions to help clinicians solve today’s two-part challenge of delivering high quality care while managing greater capacity and workflow issues, exacerbated by the impact of COVID-19. Building on continuing investments in innovation and digital health momentum, GE Healthcare is expanding... Read more

GE Healthcare Announces U.S. FDA approval of macrocyclic MRI Contrast Agent Clariscan™ (gadoterate meglumine) in Pre-Filled Syringes

U.S. FDA approves pre-filled syringe packaging for the macrocyclic gadolinium-based contrast agent, Clariscan™ (gadoterate meglumine). Clariscan has been approved in more than 70 countries globally, with more than seven million patient doses shipped, and now offers a wider range of packaging http://www.ge.com/news/press-releases/ge-healthcare-announces-us-fda-approval-of-macrocyclic-mri-contrast-agent Read more

GE Healthcare Announces First X-ray AI to Help Assess Endotracheal Tube Placement for COVID-19 Patients

Critical Care Suite 2.0 helps clinicians assess Endotracheal Tube (ETT) placement for intubated patients, including critical COVID-19 patients New AI suite includes algorithms that help radiologists prioritize critical cases and automate processes to help cut average review time from up to eight https://www.ge.com/news/press-releases/ge-healthcare-announces-first-x-ray-ai-to-help-assess-endotracheal-tube-placement-0 Read more